Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
PetIQ Inc (PETQ) Insider Trading Activity
Healthcare • Drug Manufacturers - Specialty & Generic • 1,121 employees
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.
Total Value
-$81,040,576.56
Total Shares
-2,418,886
Average Trade Value
-$4,052,028.83
Most Active Insider
First Mark L
Total Activity: $61,041,857
Largest Single Transaction
$61,010,857
by First Mark L on Oct 25, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Evp, Services Manufactured
Officer
|
Oct 25, 2024 | 8,269 | $203 | 0 | Sale to Issuer | |
Evp, General Counsel
Officer
|
Oct 25, 2024 | 3,497 | $31,000 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 12,807 | $31,000 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 14,822 | $31,000 | 0 | Sale to Issuer | |
EVP Manufacturing Sup. Chain
Officer
|
Oct 25, 2024 | 10,481 | $324,901 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 13,363 | $31,000 | 0 | Sale to Issuer | |
Chief Executive Officer
Director, Officer
|
Oct 25, 2024 | 114,027 | $8,049,991 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 1,972,687 | $61,010,857 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 14,822 | $31,000 | 0 | Sale to Issuer | |
President COO
Officer
|
Oct 25, 2024 | 88,808 | $2,500,008 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 6,077 | $31,000 | 0 | Sale to Issuer | |
Chief Executive Officer
Director, Officer
|
Oct 25, 2024 | 145,675 | $8,042,011 | 0 | Sale to Issuer | |
EVP Manufacturing Sup. Chain
Officer
|
Oct 25, 2024 | 178 | $324,901 | 0 | Sale to Issuer | |
Chief Financial Officer
Officer
|
Oct 25, 2024 | 9,800 | $31,000 | 0 | Sale to Issuer | |
Chief Financial Officer
Officer
|
Oct 25, 2024 | 16,000 | $31,000 | 0 | Sale to Issuer | |
Director
|
Oct 25, 2024 | 18,547 | $31,000 | 0 | Sale to Issuer | |
Evp, General Counsel
|
Aug 28, 2024 | 5,000 | $10,000 | 5,000 (+100.0%) | Exercise/Conversion | |
Evp, General Counsel
|
Aug 28, 2024 | 1,503 | $45,811 | 3,497 (-43.0%) | Payment of Exercise Price | |
President COO
|
Aug 5, 2024 | 22,523 | $482,893 | 97,808 (-23.0%) | Payment of Exercise Price | |
President COO
|
Aug 5, 2024 | 50,000 | $10,000 | 120,331 (+41.6%) | Exercise/Conversion |